Status:
COMPLETED
Use of Ketamine for Conscious Sedation in Flexible Bronchoscopy
Lead Sponsor:
Brooke Army Medical Center
Conditions:
Conscious Sedation
Patient Satisfaction
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
In this study, the investigators plan to conduct a single blinded randomized controlled trial in the Pulmonary Service to demonstrate the efficacy of ketamine and its utility in moderate sedation. Pat...
Detailed Description
The investigators propose to carry out a single blinded randomized controlled trial where 33 patients will receive midazolam and ketamine for sedation in one arm and 33 will receive the standard fenta...
Eligibility Criteria
Inclusion
- Patients age 18 to 75 years who present to the pulmonary clinic for bronchoscopy and considered for airway survey, transbronchial biopsy, endobronchial biopsy, or bronchoalveolar lavage.
- Provider performing the bronchoscopy
Exclusion
- Systolic blood pressure over 180mmHg and/or diastolic blood pressure over 110 on two consecutive readings
- Tachycardia greater than 120 beats/minute on two consecutive measurements
- Any allergy to ketamine, fentanyl, or midazolam
- Patient is pregnant or refuses pregnancy test,in women of child-bearing potential\*
- American Society of Anesthesiologists (ASA) score \> 3
- Presence of a history of psychosis, hallucinations, and/or a psychotic disorder
Key Trial Info
Start Date :
July 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2023
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT06181188
Start Date
July 15 2019
End Date
October 30 2023
Last Update
December 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brooke Army Medical Center
San Antonio, Texas, United States, 78234